These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

829 related articles for article (PubMed ID: 19335369)

  • 1. Forthcoming therapeutic perspectives for infections due to multidrug-resistant Gram-positive pathogens.
    Cornaglia G; Rossolini GM
    Clin Microbiol Infect; 2009 Mar; 15(3):218-23. PubMed ID: 19335369
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fighting infections due to multidrug-resistant Gram-positive pathogens.
    Cornaglia G
    Clin Microbiol Infect; 2009 Mar; 15(3):209-11. PubMed ID: 19335367
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review: dalbavancin--a novel lipoglycopeptide antimicrobial for gram positive pathogens.
    Das B; Sarkar C; Biswas R; Pandey S
    Pak J Pharm Sci; 2008 Jan; 21(1):78-87. PubMed ID: 18166524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparative review of the lipoglycopeptides: oritavancin, dalbavancin, and telavancin.
    Guskey MT; Tsuji BT
    Pharmacotherapy; 2010 Jan; 30(1):80-94. PubMed ID: 20030476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recently approved and investigational antibiotics for treatment of severe infections caused by Gram-positive bacteria.
    Appelbaum PC; Jacobs MR
    Curr Opin Microbiol; 2005 Oct; 8(5):510-7. PubMed ID: 16098786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New agents in development for the treatment of bacterial infections.
    Abbanat D; Morrow B; Bush K
    Curr Opin Pharmacol; 2008 Oct; 8(5):582-92. PubMed ID: 18761107
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infections caused by Gram-positive bacteria: a review of the global challenge.
    Woodford N; Livermore DM
    J Infect; 2009 Sep; 59 Suppl 1():S4-16. PubMed ID: 19766888
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vancomycin resistance: are there better glycopeptides coming?
    Linden PK
    Expert Rev Anti Infect Ther; 2008 Dec; 6(6):917-28. PubMed ID: 19053904
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dalbavancin and telavancin: novel lipoglycopeptides for the treatment of Gram-positive infections.
    Zhanel GG; Trapp S; Gin AS; DeCorby M; Lagacé-Wiens PR; Rubinstein E; Hoban DJ; Karlowsky JA
    Expert Rev Anti Infect Ther; 2008 Feb; 6(1):67-81. PubMed ID: 18251665
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy and safety of daptomycin: first in a new class of antibiotics for Gram-positive bacteria.
    Rybak MJ
    Clin Microbiol Infect; 2006 Mar; 12 Suppl 1():24-32. PubMed ID: 16445721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Daptomycin, a lipopeptide antibiotic in clinical practice.
    Weis F; Beiras-Fernandez A; Schelling G
    Curr Opin Investig Drugs; 2008 Aug; 9(8):879-84. PubMed ID: 18666036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Iclaprim, a novel diaminopyrimidine for the treatment of resistant gram-positive infections.
    Sincak CA; Schmidt JM
    Ann Pharmacother; 2009 Jun; 43(6):1107-14. PubMed ID: 19435963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antimicrobial resistance in Europe and its potential impact on empirical therapy.
    Rossolini GM; Mantengoli E
    Clin Microbiol Infect; 2008 Dec; 14 Suppl 6():2-8. PubMed ID: 19040461
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New treatments for methicillin-resistant Staphylococcus aureus.
    Stryjewski ME; Corey GR
    Curr Opin Crit Care; 2009 Oct; 15(5):403-12. PubMed ID: 19561492
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacodynamics of antibiotics to treat multidrug-resistant Gram-positive hospital infections.
    Pea F; Viale P
    Expert Rev Anti Infect Ther; 2007 Apr; 5(2):255-70. PubMed ID: 17402840
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oritavancin: a new avenue for resistant Gram-positive bacteria.
    Mercier RC; Hrebickova L
    Expert Rev Anti Infect Ther; 2005 Jun; 3(3):325-32. PubMed ID: 15954849
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A multivalent approach to drug discovery for novel antibiotics.
    Long DD; Aggen JB; Christensen BG; Judice JK; Hegde SS; Kaniga K; Krause KM; Linsell MS; Moran EJ; Pace JL
    J Antibiot (Tokyo); 2008 Oct; 61(10):595-602. PubMed ID: 19168973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New antibiotic agents for bloodstream infections.
    Vergidis PI; Falagas ME
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 1():S60-5. PubMed ID: 18723329
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Gram-positive bacterial infections resistant to antibiotic treatment].
    Utili R
    Ann Ital Med Int; 2001; 16(4):205-19. PubMed ID: 11799629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycopeptides: Update on an old successful antibiotic class.
    Pace JL; Yang G
    Biochem Pharmacol; 2006 Mar; 71(7):968-80. PubMed ID: 16412985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 42.